Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	43.23	-130.02	-229.01
Graham Fair Price	41.43	0.38	0.27
PEG	-97.39	< 0.005	-0.27
Price/Book	-18.34	0.14	0.17
Price/Cash Flow	18.34	-3.06	-3.75
Prices/Earnings	-59.17	0.70	1.70
Price/Sales	-59.17	2.60	6.36
Price/FCF	18.34	-3.06	-3.75
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-8.76	0.25	0.28
Operating Margin	0.00	-0.16	-0.16
ROA	100.00	0.03	0.01
ROE	0.02	0.05	100.00
ROIC	< 0.005	< 0.005	-120.57
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.11	-99.50
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	0.57	-1.00	74.16
EPS QOQ	-0.06	1.00	1466.67
FCF QOQ	-1.75	0.00	inf
Revenue QOQ	-0.80	1.00	24.39
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2530.48	1223.93	-51.63
Days Sales Outstanding (DSO)	5.29	5.96	12.69
Inventory Turnover	0.04	0.07	106.75
Debt/Capitalization	0.46	0.46	-0.03
Quick Ratio	0.19	0.21	8.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.36	0.36	< 0.005
Cash	0.04	0.04	6.26
Capex	< 0.005	< 0.005	< 0.005
Free Cash Flow	-0.02	-0.02	< 0.005
Revenue	< 0.005	0.02	100.02
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.31	1.31	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-187.72	-110.21	41.29
Naive Interpretation	Member

06 - Financial Health · Weak

Rating